Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A in Primary Adductor Tendinopathies
NCT03496649Phase 2Terminated
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- May 2019
- Primary completion
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in adductor tendinopathy, sponsored by Centre Hospitalier Universitaire de Bordeaux. Started May 2019; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
adductor tendinopathy
Beyond the preview
Go deeper on NCT03496649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03496649.